Fred Saad, MD FRCS, is Professor and Chairman of Urology, Director of G-U Oncology, and holds the Raymond Garneau Chair in Prostate Cancer Research at the University of Montreal Hospital Centre. He is the Past President of the Canadian Urologic Association, NCIC G-U Group, and Canadian Urologic Oncology Group. He sits on several prestigious editorial boards including the Lancet Oncology, JAMA Oncology, and Nature Urology. He sits on several steering committees of international clinical trials and has played a leadership role in many of the practice-changing clinical trials in advanced prostate cancer over the past 25 years. He has published more than 600 peer-reviewed articles and, with an h-factor of 123 and more than 75,000 citations, he is listed as one of the world’s most cited scientists. His research interests include novel therapeutics in prostate cancer and molecular prognostic markers and he has received more than CAD 40 million in research grants. He has received numerous awards and in 2018 was named a Knight of The National Order of Quebec, the highest honor given by the Quebec government.